This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

10 Best-Performing IPOs of 2011

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

7. Tornier (TRNX)

Company Profile: Based in Amsterdam, Tornier makes devices for joint replacement and soft-tissue repair.

Return Since IPO: 44.3%

IPO Date: Feb. 2

Offer Price: Tornier offered 8.8 million shares at $19 per share

Analyst Consensus: Tornier is also popular on Wall Street, earning seven "buy" ratings from all seven firms covering the company, including Wells Fargo Securities and JPMorgan.

6. Pacira Pharmaceuticals (PCRX - Get Report)

Company Profile: Pacira is a specialty pharmaceutical company. The company's lead drug candidate is Exparel, a long-acting anesthetic/analgesic product for postsurgical pain management.

Return Since IPO: 70.9%

IPO Date: Feb. 2

Offer Price: Pacira offered 6 million shares at $7 per share

Analyst Consensus: Pacira earns high marks with five "buy" ratings from all five research shops covering the stock. They include Piper Jaffray, Wedbush and Brean Murray.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player
3 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
FIO $0.00 0.00%
AWAY $35.49 1.60%
ECYT $4.81 0.63%
LNKD $245.66 -0.51%
PCRX $64.93 6.20%


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs